We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Updated: 2/28/2018
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)
Status: Enrolling
Updated: 2/28/2018
Click here to add this to my saved trials
Epidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position.
Updated: 3/1/2018
Epidural Contrast Flow Patterns of Transforaminal Epidural Steroid Injections Using the Inferior-Anterior Position as the Final Needle Tip Position.
Status: Enrolling
Updated: 3/1/2018
Epidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position.
Updated: 3/1/2018
Epidural Contrast Flow Patterns of Transforaminal Epidural Steroid Injections Using the Inferior-Anterior Position as the Final Needle Tip Position.
Status: Enrolling
Updated: 3/1/2018
Click here to add this to my saved trials
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Click here to add this to my saved trials
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Click here to add this to my saved trials
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Click here to add this to my saved trials
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Click here to add this to my saved trials
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Updated: 3/1/2018
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Status: Enrolling
Updated: 3/1/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Updated: 3/2/2018
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
Updated: 3/2/2018
Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide
Status: Enrolling
Updated: 3/2/2018
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
Updated: 3/2/2018
Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
Updated: 3/2/2018
Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide
Status: Enrolling
Updated: 3/2/2018
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
Updated: 3/2/2018
Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
Updated: 3/2/2018
Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide
Status: Enrolling
Updated: 3/2/2018
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
Updated: 3/2/2018
Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Mindful Hearts Study
Updated: 3/2/2018
Mindfulness Based Stress Reduction for Women at Risk for Cardiovascular Disease
Status: Enrolling
Updated: 3/2/2018
Mindful Hearts Study
Updated: 3/2/2018
Mindfulness Based Stress Reduction for Women at Risk for Cardiovascular Disease
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)
Updated: 3/2/2018
Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)
Status: Enrolling
Updated: 3/2/2018
Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)
Updated: 3/2/2018
Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke
Updated: 3/2/2018
Electrical Stimulation for Upper Limb Recovery in Stroke
Status: Enrolling
Updated: 3/2/2018
Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke
Updated: 3/2/2018
Electrical Stimulation for Upper Limb Recovery in Stroke
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke
Updated: 3/2/2018
Electrical Stimulation for Upper Limb Recovery in Stroke
Status: Enrolling
Updated: 3/2/2018
Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke
Updated: 3/2/2018
Electrical Stimulation for Upper Limb Recovery in Stroke
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke
Updated: 3/2/2018
Electrical Stimulation for Upper Limb Recovery in Stroke
Status: Enrolling
Updated: 3/2/2018
Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke
Updated: 3/2/2018
Electrical Stimulation for Upper Limb Recovery in Stroke
Status: Enrolling
Updated: 3/2/2018
Click here to add this to my saved trials
Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage
Updated: 3/4/2018
Evaluation of Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage From a Cerebral Aneurysm
Status: Enrolling
Updated: 3/4/2018
Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage
Updated: 3/4/2018
Evaluation of Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage From a Cerebral Aneurysm
Status: Enrolling
Updated: 3/4/2018
Click here to add this to my saved trials
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
Updated: 3/5/2018
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan: A Prospective Single Center, Open Label, Pilot Study
Status: Enrolling
Updated: 3/5/2018
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
Updated: 3/5/2018
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan: A Prospective Single Center, Open Label, Pilot Study
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
Myotubular Myopathy Genetic Testing Study
Updated: 3/5/2018
Myotubular Myopathy Genetic Testing Study
Status: Enrolling
Updated: 3/5/2018
Myotubular Myopathy Genetic Testing Study
Updated: 3/5/2018
Myotubular Myopathy Genetic Testing Study
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
Myotubular Myopathy Event Study
Updated: 3/5/2018
Prospective Study of Adverse Event Rates in Males With X-Linked Myotubular Myopathy
Status: Enrolling
Updated: 3/5/2018
Myotubular Myopathy Event Study
Updated: 3/5/2018
Prospective Study of Adverse Event Rates in Males With X-Linked Myotubular Myopathy
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
LAMA2-related Muscular Dystrophy Brain Study
Updated: 3/5/2018
A LAMA2-related Muscular Dystrophy Study: Brain Magnetic Resonance Imaging (MRI)and Brain Electrophysiology Evaluation
Status: Enrolling
Updated: 3/5/2018
LAMA2-related Muscular Dystrophy Brain Study
Updated: 3/5/2018
A LAMA2-related Muscular Dystrophy Study: Brain Magnetic Resonance Imaging (MRI)and Brain Electrophysiology Evaluation
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
Updated: 3/5/2018
A Randomized Trial to Evaluate Resolution of Symptoms Using Vestibular Rehab Versus Conventional Therapy in Patients Presenting to the Emergency Department (ED) With Diagnosis of Benign Paroxysmal Positional Vertigo (BPPV)
Status: Enrolling
Updated: 3/5/2018
Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
Updated: 3/5/2018
A Randomized Trial to Evaluate Resolution of Symptoms Using Vestibular Rehab Versus Conventional Therapy in Patients Presenting to the Emergency Department (ED) With Diagnosis of Benign Paroxysmal Positional Vertigo (BPPV)
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)
Updated: 3/5/2018
Evaluation of Pharmacokinetics and Profile of Clinical Response of Subacute Lisdexamfetamine Dimesylate (Vyvanse) Treatment vs. Clinical Response to Subacute Immediate Release Mixed Amphetamine Salt Therapy in Adult ADHD
Status: Enrolling
Updated: 3/5/2018
Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)
Updated: 3/5/2018
Evaluation of Pharmacokinetics and Profile of Clinical Response of Subacute Lisdexamfetamine Dimesylate (Vyvanse) Treatment vs. Clinical Response to Subacute Immediate Release Mixed Amphetamine Salt Therapy in Adult ADHD
Status: Enrolling
Updated: 3/5/2018
Click here to add this to my saved trials
Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation
Updated: 3/6/2018
Dexmedetomidine as a Rapid Bolus for Treatment and Prophylactic Prevention of Emergence Agitation in Anesthetized Children
Status: Enrolling
Updated: 3/6/2018
Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation
Updated: 3/6/2018
Dexmedetomidine as a Rapid Bolus for Treatment and Prophylactic Prevention of Emergence Agitation in Anesthetized Children
Status: Enrolling
Updated: 3/6/2018
Click here to add this to my saved trials
The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status
Updated: 3/6/2018
A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients
Status: Enrolling
Updated: 3/6/2018
The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status
Updated: 3/6/2018
A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients
Status: Enrolling
Updated: 3/6/2018
Click here to add this to my saved trials
Augmenting Balance in Individuals With Cerebellar Ataxias
Updated: 3/6/2018
Augmenting Balance in Individuals With Cerebellar Ataxias
Status: Enrolling
Updated: 3/6/2018
Augmenting Balance in Individuals With Cerebellar Ataxias
Updated: 3/6/2018
Augmenting Balance in Individuals With Cerebellar Ataxias
Status: Enrolling
Updated: 3/6/2018
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Updated: 3/6/2018
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Look AHEAD: Action for Health in Diabetes
Updated: 3/6/2018
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Updated: 3/6/2018
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Look AHEAD: Action for Health in Diabetes
Updated: 3/6/2018
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Click here to add this to my saved trials